Wealth Dimensions Group’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.31M Sell
3,596
-109
-3% -$111K 0.65% 20
2025
Q4
$3.98M Sell
3,705
-126
-3% -$120K 0.79% 19
2025
Q3
$2.92M Sell
3,831
-21
-0.5% -$15.6K 0.6% 22
2025
Q2
$3M Buy
3,852
+162
+4% +$126K 0.66% 21
2025
Q1
$3.05M Buy
3,690
+172
+5% +$143K 0.73% 19
2024
Q4
$2.72M Buy
3,518
+260
+8% +$215K 0.67% 22
2024
Q3
$2.89M Buy
3,258
+81
+3% +$72.8K 0.73% 21
2024
Q2
$2.88M Sell
3,177
-65
-2% -$52K 0.82% 19
2024
Q1
$2.52M Buy
3,242
+260
+9% +$185K 0.74% 21
2023
Q4
$1.74M Sell
2,982
-512
-15% -$299K 0.55% 32
2023
Q3
$1.88M Sell
3,494
-18
-0.5% -$9.28K 0.68% 25
2023
Q2
$1.65M Buy
3,512
+350
+11% +$147K 0.6% 30
2023
Q1
$1.09M Buy
3,162
+158
+5% +$53.3K 0.42% 37
2022
Q4
$1.1M Sell
3,004
-71
-2% -$25.2K 0.45% 35
2022
Q3
$994K Buy
3,075
+61
+2% +$19.3K 0.49% 32
2022
Q2
$977K Sell
3,014
-108
-3% -$32.4K 0.46% 33
2022
Q1
$894K Buy
3,122
+52
+2% +$13.4K 0.41% 42
2021
Q4
$848K Sell
3,070
-4
-0.1% -$1.01K 0.42% 41
2021
Q3
$710K Hold
3,074
0.45% 44
2021
Q2
$706K Sell
3,074
-13
-0.4% -$2.61K 0.48% 41
2021
Q1
$577K Sell
3,087
-59
-2% -$11.5K 0.45% 45
2020
Q4
$531K Buy
+3,146
New +$470K 0.46% 41

Other funds holding LLY

Wealth Dimensions Group's LLY Position: Q1 2026 in Review

Wealth Dimensions Group reduced its Eli Lilly (LLY) stake by 2.9% in Q1 2026, selling an estimated $111K and leaving 3,596 shares worth $3.31M. The position accounts for 0.65% of the portfolio, ranked #20.

Wealth Dimensions Group first reported a position in LLY in Q4 2020 and has held it in 22 quarters since. The position peaked at $3.98M in Q4 2025. 4,352 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Wealth Dimensions Group held 3,596 shares of Eli Lilly worth $3.31M as of Q1 2026.
  • Wealth Dimensions Group sold 109 Eli Lilly shares in Q1 2026, an estimated $111K.
  • Eli Lilly made up 0.65% of Wealth Dimensions Group's portfolio in Q1 2026, its #20 holding.
  • Wealth Dimensions Group first reported a position in Eli Lilly in Q4 2020 and has held it in 22 quarters since.
  • Wealth Dimensions Group's Eli Lilly position peaked at $3.98M in Q4 2025.
  • 4,352 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Wealth Dimensions Group's 13F filing for Q1 2026, filed 12 May 2026.